tiprankstipranks
Celularity (CELU)
NASDAQ:CELU
US Market
Holding CELU?
Track your performance easily

Celularity (CELU) Income Statement

182 Followers

Celularity Income Statement

Last quarter (Q ), Celularity's total revenue was $9.30M, an increase of 145.54% from the same quarter last year. In Q, Celularity's net income was $-16.10M. See Celularity’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 48.20M$ 22.77M$ 17.98M$ 21.34M$ 14.28M
Cost of Revenue
$ 17.25M$ 16.02M$ 19.66M$ 9.65M$ 4.93M
Gross Profit
$ 30.95M$ 6.75M$ -1.69M$ 11.68M$ 9.35M
Operating Expense
$ 198.90M$ 83.23M$ 146.58M$ 206.68M$ 145.69M
Operating Income
$ -15.76M$ -192.29M$ -25.60M$ -109.06M$ -151.93M
Net Non Operating Interest Income Expense
--$ -365.00K-$ 1.78M
Other Income Expense
$ 5.44M$ -3.47M$ -42.47M$ -2.96M$ 190.41M
Pretax Income
$ -35.04M$ -196.28M$ 14.21M$ -100.10M$ -212.93M
Tax Provision
$ 10.00K$ 10.00K$ 13.00K$ 20.00K$ -4.70M
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -24.12M$ -185.37M$ -109.42M$ -100.12M$ -208.23M
Basic EPS
$ -1.28$ -11.02$ 1.00$ -1.49-
Diluted EPS
$ -1.28$ -11.02$ 0.90$ -1.49$ -0.45
Basic Average Shares
$ 84.49M$ 17.81M$ 13.99M$ 67.06M$ 8.68M
Diluted Average Shares
$ 84.49M$ 17.81M$ 14.98M-$ 8.68M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 216.16M$ 99.25M$ 166.24M$ 366.37M$ 229.73M
Net Income From Continuing And Discontinued Operation
$ -35.05M$ -196.29M$ 14.19M$ -100.12M$ -208.23M
Normalized Income
$ -36.60M$ -42.72M-$ -75.55M-
Interest Expense
-----
EBIT
$ -90.29M$ -196.28M$ 14.21M$ -96.93M$ -210.58M
EBITDA
$ -81.94M$ -186.96M$ 23.64M$ -88.11M$ -202.41M
Currency in USD

Celularity Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis